N/A N=24 Randomized Single-blind Treatment

A Comparison Between GUMMETAL and SS Orthodontic Wires in Space Closure

Malocclusion, Angle Class I

Bottom Line

View on ClinicalTrials.gov: NCT04591080 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2024

Primary outcome: Primary: Total Amount of Canine Retraction — 3.41; 3.71 mm

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: GUMMETAL Orthodontic Wire (Device); Stainless Steel (CrNi) (Device)
Age: Pediatric · 12+ yrs
Sex: All
Sponsor: State University of New York at Buffalo
Primary completion: Mar 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Total Amount of Canine Retraction	3.41; 3.71	—
SECONDARY 3-Dimensional Control of Canine Movement Assessment	7.90; 7.25	—
SECONDARY Rate of Canine Retraction Per Month	1.14; 1.42	—

Summary

When there is space present between our teeth orthodontically we have the ability to close them through many methods. Using braces as our treatment modality this study will be investigating how efficient a new orthodontic wire is in closing tooth space. This new material is trade-named GUMMETAL and claims to have many benefits to treating patients orthodontically. We will be exploring its efficiency in space closure compared to an industry standard (stainless steel). We predict that the stainless-steel orthodontic wire will be more efficient at space closure than the new GUMMETAL wires.

Eligibility Criteria

Inclusion Criteria

Full permanent dentition (except third molars)
Good general and oral health
Bilateral spaces 3 >/= mm distal to the maxillary canines
Normal and hypodivergent growth pattern
Any dental malocclusion
Good Oral Hygiene

Exclusion Criteria

Systemic diseases or syndrome
Abnormalities in teeth size and/or shape
Previous orthodontic treatment
Anti-inflammatory medication
Craniofacial anomalies
Hyperdivergent growth pattern
Periodontal disease / attachment loss exceeding 25% of root length
Significant pre or in-treatment root resorption

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04591080). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.